US Rhinoplasty Market Overview
As per MRFR analysis, the US Rhinoplasty Market Size was estimated at 3.15 (USD Billion) in 2024. The US Rhinoplasty Market Industry is expected to grow from 3.40 (USD Billion) in 2025 to 6.80 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 8.00% during the forecast period (2025 - 2034). The rising number of individuals seeking aesthetic enhancements via surgical interventions and launching technologically cutting-edge treatment techniques such as 3D computer-assisted technologies are the prominent market drivers anticipated to propel the US rhinoplasty market.

Source: Primary Research, Market Research Future Database, Secondary Research, and Analyst Review
Rhinoplasty Market Trends
Increasing product launches by key players is driving the market growth
The US rhinoplasty market CAGR is expanding due to the rising product launches by major players. Launching any product for rhinoplasty procedures is precisely governed by specific regulations whose support is necessary to establish new products. The expanding adoption of cosmetic surgeries among celebrities and growing awareness regarding cosmetic surgeries are anticipated to drive the rhinoplasty market revenue. For instance, in February 2023, Acclarent, Inc., a part of Johnson and Johnson companies, launched RELIEVE SPINPLUS Balloon Sinuplasty Systems.
Using endoscopic techniques, the balloon sinuplasty system enables qualified otolaryngologists to dilate obstructed sinus ostia and passageways in patients suffering from sinusitis and difficulties in breathing, and it is also used in reshaping the nose.
Furthermore, the revenue growth of the rhinoplasty market is also seeing an expansion due to the prevalence of nasal deformities and respiratory ailments such as chronic sinusitis, sleep apnea, and deviated septum. Rhinoplasty, an increasingly sought-after treatment, delivers a promising solution to improve nasal functionality and alleviate signs like breathing difficulties and snoring. The expansion in revenue of the rhinoplasty market is driven by improvements in surgical techniques and cutting-edge technology. The procedure's precision and accuracy have significantly enhanced, owing to the use of computer-aided design and three-dimensional imaging, thereby making it safer and more efficient.
Moreover, presenting innovative surgical instruments and adopting minimally invasive procedures have substantially decreased post-operative discomfort and recovery periods, enhancing overall patient satisfaction.
Rhinoplasty Market Segment Insights
Rhinoplasty Treatment Type Insights
The US rhinoplasty market segmentation, based on the treatment type, includes augmentation, post-traumatic, reduction, reconstructive, revision, filler, and others. The augmentation rhinoplasty segment dominated the market mostly due to its use in improving the structure and function of the nose. The growing demand for cosmetic enhancements, with patients seeking nasal reshaping and improved facial aesthetics. Augmentation nose surgery is one of the most typical cosmetic techniques in regions such as Asia, with silicone implants being the most widely embraced material for augmentation nose reshaping surgery.
It has many advantages and is a very helpful procedure option for patients who have an aversion to the usage of artificial implants.
Rhinoplasty Technique Insights
The US rhinoplasty market segmentation, based on technique, includes open rhinoplasty and closed rhinoplasty. Open rhinoplasty held a major market share owing to its ability to undertake complicated and extensive nose surgery. The surgical technique's ability to provide enhanced visibility and precise surgical modifications for optimal results. Open rhinoplasty is used as cosmetic surgery to improve not only the aesthetics of a person but also the functionality of the nose. The natural exposure and improved visibility to the operating area permit an open rhinoplasty to enhance the position of the nose and hence the unrestricted air flow breathing.
Figure 1: US Rhinoplasty Market, by Technique, 2023 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review
Rhinoplasty Country Insights
The rhinoplasty market in the US is propelled by rising income levels, increasing interest in physical appearance, and medical tourism, which are favorably embraced due to the low expenses of procedures and rising improvements in healthcare infrastructure. Increasing societal emphasis on facial aesthetics, a desire for personalized beauty, and technological advancements in surgical techniques contribute to the market's growth. Additionally, a rising awareness of rhinoplasty's potential psychological and social benefits fuels its popularity. Functional aspects, such as improved breathing and correction of nasal deformities, further drive demand.
The competitive landscape, including skilled surgeons and innovative procedures, reinforces the market, making rhinoplasty a sought-after cosmetic and reconstructive procedure in the dynamic and evolving landscape of aesthetic surgery in the US.
Rhinoplasty Key Market Participants & Competitive Insights
Major market participants are investing heavily in research and development to enhance their product lines, which will help the rhinoplasty market expand even more. Market participants are also undertaking numerous strategic activities to expand their footprint, with substantial market developments including recent product establishment, mergers and acquisitions, contractual agreements, and collaboration with other organizations. The rhinoplasty industry must deliver cost-effective items to extend and stay in a more competitive and increasing market climate.
Major players in the rhinoplasty market are attempting to expand market requirements by investing in research and development operations, including Stryker, Sunset Cosmetic Surgery, Implantech, Grover Aesthetics, GC Aesthetics, and Surgiform Technologies LLC.
Key Companies in the Rhinoplasty market include
- Stryker
- Grover Aesthetics
- Sunset Cosmetic Surgery
- Implantech
- GC Aesthetics
- Surgiform Technologies LLC
US Rhinoplasty Industry Developments
- Q2 2024: Stryker launches new 3D-printed nasal implant for rhinoplasty procedures in the U.S. Stryker announced the commercial launch of its latest 3D-printed nasal implant, designed to improve outcomes in rhinoplasty surgeries, marking its entry into the U.S. rhinoplasty device market.
- Q1 2024: Allergan Aesthetics receives FDA approval for new injectable filler for non-surgical rhinoplasty Allergan Aesthetics, an AbbVie company, secured FDA approval for its new hyaluronic acid-based injectable filler, specifically indicated for non-surgical rhinoplasty, expanding its facial aesthetics portfolio.
- Q3 2024: Establishment Labs Announces U.S. Commercial Launch of Motiva Ergonomix2® for Rhinoplasty Applications Establishment Labs began U.S. commercial distribution of its Motiva Ergonomix2® implant, now cleared for use in rhinoplasty procedures, following recent regulatory clearance.
- Q2 2025: Johnson & Johnson MedTech acquires startup NasalTech to expand rhinoplasty solutions portfolio Johnson & Johnson MedTech completed the acquisition of NasalTech, a U.S.-based startup specializing in minimally invasive rhinoplasty devices, to strengthen its position in the surgical aesthetics market.
- Q1 2025: InMode Ltd. announces partnership with American Academy of Facial Plastic and Reconstructive Surgery InMode Ltd. entered a strategic partnership with the American Academy of Facial Plastic and Reconstructive Surgery to advance education and adoption of its radiofrequency-assisted rhinoplasty technology in the U.S.
- Q4 2024: Sientra appoints Dr. Emily Carter as Chief Medical Officer to lead rhinoplasty product development Sientra announced the appointment of Dr. Emily Carter as Chief Medical Officer, with a focus on accelerating innovation in its rhinoplasty and facial implant product lines.
- Q2 2024: Silicone Arts Laboratories secures $20 million Series B funding to expand U.S. rhinoplasty implant manufacturing Silicone Arts Laboratories raised $20 million in Series B funding to scale up its U.S. manufacturing operations for advanced silicone implants used in rhinoplasty procedures.
- Q3 2025: Mentor Worldwide LLC opens new R&D facility in California focused on facial and rhinoplasty implants Mentor Worldwide LLC inaugurated a new research and development facility in Irvine, California, dedicated to innovation in facial and rhinoplasty implant technologies.
- Q1 2024: Galderma launches Restylane Contour for non-surgical rhinoplasty in the U.S. Galderma introduced Restylane Contour, a hyaluronic acid filler, for non-surgical rhinoplasty applications in the U.S. market, expanding its dermal filler portfolio.
- Q2 2025: Revance Therapeutics receives FDA clearance for RHA Redensity dermal filler for nasal contouring Revance Therapeutics announced FDA clearance for its RHA Redensity dermal filler, now indicated for nasal contouring and non-surgical rhinoplasty in the U.S.
- Q4 2024: Zimmer Biomet acquires minority stake in 3D Nose Solutions, a U.S. rhinoplasty planning software firm Zimmer Biomet acquired a minority equity stake in 3D Nose Solutions, a company specializing in digital planning software for rhinoplasty, to enhance its digital surgery offerings.
- Q3 2024: Apyx Medical secures contract with major U.S. hospital network for J-Plasma device in rhinoplasty procedures Apyx Medical signed a supply contract with a leading U.S. hospital network for its J-Plasma device, which is increasingly used in minimally invasive rhinoplasty surgeries.
Rhinoplasty Market Segmentation
Rhinoplasty Treatment Type Outlook
- Augmentation
- Reduction
- Post-traumatic
- Reconstructive
- Revision
- Filler
- Others (Ethnic Rhinoplasty, Refinement Rhinoplasty)
Rhinoplasty Technique Outlook
- Open Rhinoplasty
- Closed Rhinoplasty
Report Attribute/Metric |
Details |
Market Size 2024 |
3.15 (USD Billion) |
Market Size 2025 |
3.40 (USD Billion) |
Market Size 2034 |
6.80 (USD Billion) |
Compound Annual Growth Rate (CAGR) |
8.00 % (2025 - 2034) |
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Base Year |
2024 |
Market Forecast Period |
2025 - 2034 |
Historical Data |
2020 - 2024 |
Report Coverage |
Growth Factors, Revenue Forecast, Market Competitive Landscape, and Trends |
Segments Covered |
Treatment Type, Technique, and Region |
Countries Covered |
The US. |
Key Companies Profiled |
Stryker, Sunset Cosmetic Surgery, Grover Aesthetics, Implantech, GC Aesthetics, and Surgiform Technologies LLC |
Key Market Opportunities |
· Increasing product launches by key players |
Key Market Dynamics |
· An increasing number of individuals seeking aesthetic enhancements through surgical interventions |
Frequently Asked Questions (FAQ):
The US rhinoplasty market size was valued at USD 2.5 Billion in 2022.
The market is anticipated to expand at a CAGR of 8.00% during the forecast period, 2025-2034.
The prominent players in the Rhinoplasty market are Stryker, Grover Aesthetics, Implantech, GC Aesthetics, Sunset Cosmetic Surgery, and Surgiform Technologies LLC.
The augmentation segment dominated the market in 2022.
The open rhinoplasty category had the largest share of the market.